I see many patients who say, Ill just wait for the new triple drug. As a doctor, I strongly advise against this strategy for three reasons: Obesity is a progressive disease
Tirzepatide for Obesity Treatment and Diabetes Prevention Published November 13, 2024 N Engl J Med 2025;392:958-971 DOI: 10.1056/NEJMoa2410819 Abstract Background Obesity is a chronic disease and causal precursor to myriad other conditions, including type 2 diabetes
MDWatch changed everything
The FDA label states that tirzepatide "may impact the efficacy of oral hormonal contraceptives" and recommends patients switch to a non-oral contraceptive method or add a barrier method for 4 weeks after initiation and 4 weeks after each dose escalation [3]
Wszystko to sprawia, e agonici GLP-1 reprezentuj obecnie jeden z najbardziej fascynujcych i obiecujcych nurtw w leczeniu chorb metabolicznych
For weight loss alone it is typically on a self-pay basis, though consultations and labs may be covered